Blood pressure variability predicts adverse events and cardiovascular outcomes in <scp>SPRINT</scp>
Kenechukwu Mezue(University of the Commonwealth Caribbean), Janani Rangaswami, Jay Horrow(Wilmington University), Gregg S. Pressman(Einstein Medical Center Philadelphia), Roy Matthew(Albany Medical Center Hospital), Abhinav Goyal
Cited by 39
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
|Journal of the American College of Cardiology|2010|538
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
|Journal of the American College of Cardiology|2025|346